Yichang HEC Changjiang Pharmaceutical Co. Ltd. Discloses Internal Dealings Involving Equity Swaps and Commercial Paper in Privatisation Effort

Reuters

25 Jun

Yichang HEC Changjiang Pharmaceutical Co. Ltd. Discloses Internal Dealings Involving Equity Swaps and Commercial Paper in Privatisation Effort

Yichang HEC ChangJiang Pharmaceutical Co., Ltd. has disclosed internal dealings under Rule 22 of the Hong Kong Code on Takeovers and Mergers. CICC Wealth Investment Limited, an exempt principal trader connected with the Offeror, executed transactions involving other types of securities on 24 June 2025. The dealings were made for its own account, with a sale of 1,200 shares and a purchase of 1,200 shares. CICC Wealth Investment Limited is ultimately owned by China International Capital Corporation Limited.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 25, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2546904042"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546904042\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2546904042?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-25 17:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546904042","market":"fut","top_or_hot":-1,"title":"Yichang HEC Changjiang Pharmaceutical Co. Ltd. Discloses Internal Dealings Involving Equity Swaps and Commercial Paper in Privatisation Effort","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Yichang HEC Changjiang Pharmaceutical Co. Ltd. Discloses Internal Dealings Involving Equity Swaps and Commercial Paper in Privatisation Effort\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Yichang HEC ChangJiang Pharmaceutical Co., Ltd. has disclosed internal dealings under Rule 22 of the Hong Kong Code on Takeovers and Mergers. CICC Wealth Investment Limited, an exempt principal trader connected with the Offeror, executed transactions involving other types of securities on 24 June 2025. The dealings were made for its own account, with a sale of 1,200 shares and a purchase of 1,200 shares. CICC Wealth Investment Limited is ultimately owned by China International Capital Corporation Limited.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yichang HEC Changjiang Pharmaceutical Co. Ltd. Discloses Internal Dealings Involving Equity Swaps and Commercial Paper in Privatisation Effort</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYichang HEC Changjiang Pharmaceutical Co. Ltd. Discloses Internal Dealings Involving Equity Swaps and Commercial Paper in Privatisation Effort\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-25 17:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Yichang HEC Changjiang Pharmaceutical Co. Ltd. Discloses Internal Dealings Involving Equity Swaps and Commercial Paper in Privatisation Effort\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Yichang HEC ChangJiang Pharmaceutical Co., Ltd. has disclosed internal dealings under Rule 22 of the Hong Kong Code on Takeovers and Mergers. CICC Wealth Investment Limited, an exempt principal trader connected with the Offeror, executed transactions involving other types of securities on 24 June 2025. The dealings were made for its own account, with a sale of 1,200 shares and a purchase of 1,200 shares. CICC Wealth Investment Limited is ultimately owned by China International Capital Corporation Limited.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01558","symbol_name":"东阳光长江药业","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL1lNqZD:1","article_id":"2546904042","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546904042","pubTimestamp":1750843365,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Yichang HEC Changjiang Pharmaceutical Co. Ltd. Discloses Internal Dealings Involving Equity Swaps and Commercial Paper in Privatisation Effort. Yichang HEC ChangJiang Pharmaceutical Co., Ltd. has disclosed internal dealings under Rule 22 of the Hong Kong Code on Takeovers and Mergers. CICC Wealth Investment Limited, an exempt principal trader connected with the Offeror, executed transactions involving other types of securities on 24 June 2025. The dealings were made for its own account, with a sale of 1,200 shares and a purchase of 1,200 shares. CICC Wealth Investment Limited is ultimately owned by China International Capital Corporation Limited.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. L","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601995":"中金公司","01558":"东阳光长江药业","BK1515":"抗疫概念","BK0276":"资本市场","BK1191":"制药"},"translate_title":"宜昌东阳光长江药业有限公司披露私有化过程中涉及股权置换和商业票据的内部交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601995":0.9,"01558":0.9},"content_text":"Yichang HEC Changjiang Pharmaceutical Co. Ltd. Discloses Internal Dealings Involving Equity Swaps and Commercial Paper in Privatisation Effort\n    \n\n        Yichang HEC ChangJiang Pharmaceutical Co., Ltd. has disclosed internal dealings under Rule 22 of the Hong Kong Code on Takeovers and Mergers. CICC Wealth Investment Limited, an exempt principal trader connected with the Offeror, executed transactions involving other types of securities on 24 June 2025. The dealings were made for its own account, with a sale of 1,200 shares and a purchase of 1,200 shares. CICC Wealth Investment Limited is ultimately owned by China International Capital Corporation Limited.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 25, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}